A good result, what we expected and hoped for. Now onto the trial proper with multiple patients while they experiment with different dosages and all the boring stuff. Unless something momentous happens we probably wont hear a lot more until June, which is not far away.
First hurdle cleared now onto the next.
Lots to like here. There is a reason why Chimeric has been able to poach such experienced talent from safe secure jobs and it is something called potential rewards.
Keep watching the company and ignore the share price. If you happy with 20% profit you should be happy in the second half of the year, but if your in for serious and big rewards keep accumulating and look out to 2 - 3 years.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)